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Determination of tumor volume in subcutaneously inoculated xenograft models is a standard procedure for clinical
and preclinical evaluation of tumor response to treatment. Practitioners frequently use a hands-on caliper method
in conjunction with a simplified formula to assess tumor volume. Non-invasive and more precise techniques as
investigation by MR or (μ)CT exist but come with various adverse effects in terms of radiation, complex setup or
elevated cost of investigations. Therefore, we propose an advanced three-dimensional sonographic imaging
technique to determine small tumor volumes in xenografts with high precision and minimized observer variability.
We present a study on xenograft carcinoma tumors from which volumes and shapes were calculated with the
standard caliper method as well as with a clinically available three-dimensional ultrasound scanner and
subsequent processing software. Statistical analysis reveals the suitability of this non-invasive approach for the
purpose of a quick and precise calculation of tumor volume in small rodents.
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For a couple of years and despite most recent advances in tumor
research, still the display of tumor growth as a clinically and pre-clinically
relevant factor for prognosis and development of a cancerous diseases
remains important. A decrease or increase in tumor size is in most cases
directly linked to a response or non-response to tumor treatment [1].
Conventionally, growth of solid tumors is followed under various
conditions, e.g. different treatment regimes, and then assessed by
regularly tracking increase in volume of the xenografts that are initially
created by subcutaneously injecting tumor cells in immune-deficient
small rodents like mice. However, the methods for volume
measurement used by practitioners is involving a mere mechanical
in vivo calipermeasurement of length andwidth directly on anaesthetized
tumor-bearing mice, and a subsequent calculation of an approximate
tumor volumewith a formula derived fromGeran et al. [2]. This widely
used equation is an altered version of the calculation used for
determination of an ellipsoid volume: π/6 w(idth) d(epth) l(ength)
and, assuming the depth to be approximately the same as the width, it
becomes π/6 w w l or π/6 (short axis) (short axis) (long axis).
The main disadvantage of this method evidently becomes clear: it
is imprecise because tumors, especially human xenograft linestransplanted and grown in mice, often undergo shape changes that
considerably deviate from an ellipsoid volume. Additionally, the
measurement overestimates tumor size because the uppermost skin
layers (dermis and epidermis) above the tumor hull are not taken
into consideration. Furthermore, the method of measuring with
calipers in the sub-millimeter range on tumors which tend to
perform evasive subcutaneous movements is also highly influenced
by intra-observer variabilities.
In contrast to the study of Ayers et al. [3] our method does not
necessarily require the excision of the tumors to determine the tumor
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circumvent this problem by using ultrasound in a 2D-segmentational
analysis as a non-invasive tool to determine exact tumor volume [4].
Many of these investigations focused on clinical questions, regarding
e.g. the high frequency sonographic imaging of small animals for
pathogenesis and embryonic development of mice [5,6]. Also, two
dimensional imaging modalities as ultrasound bio-microscopy
(UBM) and scanning acoustic microscopy (SAM) have been used
to investigate tumors in a non-invasive fashion [4,7]. Earlier studies
shed light on the suitability of ultrasound in quantifying tumor
volume, first on phantom models in 3D ultrasound compared with a
2D ultrasound approach [8]. As the technique progressed, 3D
ultrasound became more widely used, as in a clinical setting on small
metastatic nodular tumor entities [9] or as a common tool to visualize
organs in different orientations [10]. However, none of these so far
used the possibilities which 3D-ultrasound combined with speckle
tracking has to offer. Not only is it possible to generate a complete
three-dimensional rendering of the tumor, but the integrated software
with a speckle tracking detection and wall motion tracking algorithm
makes precise volume determination possible. At a sonographic
frequency of 2.5 MHz or higher, the approximate wavelength of 0.4
to 0.6 mm is sufficient for imaging the typical tumor dimensions of
larger subcutaneous and hypertensed tumors in the range of 4 to 6 cm
length. Due to the attenuation not being directly proportional to
fourth power of frequency like in solid materials [11], but rather it
being in the range of f^1 to f^2 [12], the low frequency of 2.5 to
4 MHz used here does still not suffer significantly from the typical
wave attenuation in soft tissues. High frequency approaches
(e.g. UBM and SAM performed between 5 to 30 MHz, or higher)
are thus limited in the depth of penetration of the ultrasonic waves.
In the present study we propose a 3D sonographical approach at
4 MHz to determine exact tumor volume, without employing
microbubbles or similar binding-agent techniques on 11 vulva-
carcinoma A431 tumors. Accuracy and results of this method are
hence compared to the results of conventional caliper measurements
as well as to the procedure of determining volume by weighing with
general tissue density assumptions. The latter one can be considered
as the gold standard method, as displayed in Ayers et al. [3]. We show
that the ultrasound method used is suitable for ex vivo transplants and
yields highly reliable tumor volume representations, considering our
technology as applicable for in vivo measurements as well. This data,
in turn, can be used in non-invasive ultrasound studies on
biomechanical parameters such as TIFP to facilitate data processing
and visualize even small changes in tumor volume due to the release or
increase of internal tumor pressure.
Materials and Methods
Cell Culture
Vulva-carcinoma derived epithelial A431 cells were cultured in
low-glucose DMEM medium with 10 % FCS (fetal calf serum) and
1% PS (penicilline/streptomycine) at 37°C under 5% CO2
atmosphere. When a cell density of 1 × 107 cells per flask was
reached, cells were harvested and diluted in PBS (phosphate-buffered
saline) solution for tumor cell inoculation.
Animal Experiments
5 × 106 cells were subcutaneously injected into both flanks of six to
eight weeks old immune-compromised female NMRI (Naval MedicalResearch Institute) nu/nu mice. Food and water were given
ad libitum. In total, 12 mice were used and 18 tumors were assessed
in the different experiments. In some animals only one tumor was
used for measurements due to increased growth compared to the
second implanted tumor. Caliper measurements of tumor length and
width were performed at three-day intervals with Vernier calipers
(digital 6”/150 mm steel calipers with 0.01 mm resolution; Neiko
Tools, USA)(Supplementary Table 1). Mice were anaesthetized with
Isoflurane® (Abbott GmbH, Wiesbaden, Germany; 2% vaporized in
oxygen). Tumors were grown for 14 to 21 days depending on the
growth rate of individual tumors but not exceeding 20% of total
bodyweights of the animals. Mice were sacrificed with tumors left in
place for immediate in vivo ultrasonic investigation and later carefully
excised for ex vivo ultrasonic investigation. All animal experiments
were conducted and approved in accordance with the German animal
welfare regulations (Regierungspräsidium Darmstadt, F79/47).
Ultrasonic Investigation
For ex vivo ultrasonic investigation, all tumors were placed in a water
bath (Aqua dest.) at 25°C. Three-dimensional ultrasonic measurements
were conducted using a commercial 3D sonographic instrument
(ARTIDA Systems) developed by Toshiba Medical Systems Company
(Tochigi, Japan). The probe was installed in a stand-off device during
data acquisition (Suppl. Figure 1). Ex vivo image acquisition were
performed using 3D transducers at 4 MHz center frequency. The high
resolution images (DICOM format) were acquired by dividing the
tumor into six virtual segments at 1 Hz time synchronization frequency
with a line density of the synchronized segmentation at 3000 sampling
points. The frame numbers were optimized at 12 frames/second
because, as the tumors were static, the lower resolution in time leads to a
higher spatial resolution. As the acoustic impedance mismatch between
water and tumor results in a pronounced gray scale contrast along the
boundaries, this threshold contrast could be used to detect them along
the coupling fluid/tissue interface.
Signal Analysis and 3D Data Processing
To generate 3D representations of the tumors, speckle tracking and
a 3D wall motion tracking (3D-WMT) algorithm with an output of
36 × 36 data points in radial and longitudinal directions was
implemented. The speckle density was determined in 1 cm3 blocks
and an 8-node block matching speckle tracking algorithm was used
with an image resolution of 0.43 mm/pixel. The algorithm was
implemented on two mutually orthogonal sections of the tumor and
three longitudinal sections as shown exemplarily for the in situ
situation of an A431 tumor in Supplementary Figure 2.
It generates three dimensional Cartesian coordinates along the
geometry of the tumor which can be visualized in a standard
ultrasonic contrast image (Figure 1A) as well as in a “plastic bag”
wireframe display (Figure 1B), which are also suited for a subsequent
import in MATLAB (MathWorks, R2012a) software. The visuali-
zation facilitates rendering in space and the evaluation of tumor
inhomogeneity. The final volume of the tumor was calculated by
product of the cross section area of the radial slices and the thickness
of the corresponding longitudinal section.
Statistical Analysis
Statistics were performed with one- and two-way ANOVA
standard tests for analysis of significance. Confidence levels were
chosen at 95% confidence-interval.
Figure 1. Tumor imaging utilizing the 4 MHz ultrasound ARTIDA scanning system. A) Volumetric representations of ten experimental
A431 tumors. B) Stress load mesh volumes (“plasticbag” wireframe) of ten experimental A431 tumors.
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Tumor Volume Determination Using a Speckle
Tracking Algorithm
The main purpose of this work was to investigate how accurate 3D-
ultrasound with a new speckle tracking algorithm can obtain
reasonable tumor volume estimates in comparison to the standard
technique conventionally based on caliper measurements and volume
calculation with the formula derived from Geran et al. [2]. For ten
exemplary tumors in our studies, the live B-Mode grey image
acquisition window in x-y plane direction is shown in Figure 1A,
including the superimposed semi-automatic outline path which
marks individual tumor boundaries. The dotted, innermost signal
line, colored in yellow, was taken to indicate and interpolate the most
probable boundary between tumor tissue and signal reflections from
the surroundings. Density from tissue (tumor and microenviron-
ment) makes for the main grey value contrast whereas backscatteringof the signal at the bottom of the plane and the tumor/plane interfaces
creates noise distortions, as can be seen in the sagittal cut portions of
the display. In cases where the loop path ends could not be fully
closed at one tip of the tumor, the remaining path was interpolated
automatically with minimized error. The resulting volumetric
representations for the exact same 10 experimental tumors, including
a hypothetical estimate on potential circumferential strain loads, are
shown in a so-called “plastic bag” simulation (Figure 1B). The
potential strain loads, assumed automatically by the software, can be
neglected in all cases, as we did not load the tissues with any prestress.
Interestingly, a wide variety of tumor hull geometries can be
identified in an otherwise homogenous set of these subcutaneous
samples of A431-tumors.
VolumeMeasurements for Tumors are Established andCompared
In order to corroborate the differences we expected to find between
the two methods—tumor volume acquisition by ultrasound
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standard) method had to be employed to determine an assumed true
tumor volume. The true tumor volume was calculated according to
the established method by Ayers et al. [3] by determining tumor
weight and calculating volume with a known or expected tissue
density according to:
Tumor volume VTð Þ ¼ tumor mass MTð Þ=tissue density ρð Þ:
The average value for tissue density assumed with our calculations
was ρ = 0.85 g/cm3, and assumed from the literature as given in [13],
it was ρ = 1 g/cm3, resulting in tumor volumes Vw or VL,
respectively. Table 1 shows the results for tumor volume measure-
ments on seven A431 tumors, indicating next to both gold standard
volumes (Vw, VL) the caliper/formula derived volume VE and the
ARTIDA-calculated volume VA for each individual tumor.
TIFP Pressure Values Correlate in Part with Tumor Volumes
An intrinsic phenomenon on most solid tumors, generated by the
chaotic nature of their blood vessel supply and dysfunctional lymph
drainage in the tumor, is an elevated tumor interstitial fluid pressure
(TIFP). It can account for upholding a large portion of the final
tumor volume and shape. Supplementary Figure 3 shows TIFP
values measured via the wick-in-needle technique in relation to
respective (ARTIDA calculated) tumor volumes for a larger set of
A431 tumors, reaching volumes up to 3300 mm3 and TIFP values
up to 11 mmHg. Measurements were performed as described
previously [1]. Though, a strictly linear correlation between fluid
pressure and tumor volume cannot be identified, a general increase of
interstitial fluid pressure with a rising volume can be reasonably
assumed and observed for most cases. A lot of data points tend to
accumulate around certain volume/TIFP values, such as seen here
between volume values around V = 800 to 1200 mm3 and TIFP
values around 4 to 5 mm Hg.
Tumor Volumes Are More Accurately Assessed by Ultrasound/
ARTIDA Than by Caliper/Formula
Tumor volumes have been calculated for all A431 tumors by the
conventional caliper/formula method and by ultrasound with the
ARTIDA system. Comparing ARTIDA-calculated tumor volumes to
the volumes derived from the caliper/ellipsoid formula calculations
and referenced to the gold standard volume determination method
(with literature density values), as it is shown in Figure 2A. The
difference of VA volumes to the true tumor volume VL is considerably
smaller than the significant difference of VE to VL volumes. Moreover,
the same observation is made in the case when we use the other
estimation for tumor tissue density from our own calculations as the
true tumor volume (Vw), as displayed in Figure 2B. Though theTable 1. Volume measurement on a subset of seven A431 tumors
Table indicating tumor volumes obtained by a) calculation from fresh weight with weight-derived density estima
caliper determination (VE) and c) estimation by ARTIDA-speckle tracking algorithm at 4 MHz (VA)
Code Origin, treatment Volume [mm3] VW
Tumor 1 A431, none 875.9
Tumor 2 A431, none 847.0
Tumor 3 A431, none 657.2
Tumor 4 A431, none 470.0
Tumor 5 A431, none 351.4
Tumor 6 A431, none 801.1
Tumor 7 A431, none 1073.3differences between VA and VE are smaller than in Figure 2A, still it
can be considered that ARTIDA-calculated volumes VA are closer
to the true tumor volume VW than the ellipsoid/caliper-calculated
volumes VE. Additionally, a Bland-Altman plot reveals differences
in volume estimations for both methods around the range of 1 SD
(1 SD =396 mm3), and accumulating around the distribution of
tumor volumes between 350 and 750 mm3 (Figure 2C). Similar
differences between the two methods are revealed by the
corresponding correlation curve to the Bland-Altman plot
(Figure 2D). The resulting linearly fitted correlation curve
considerably deviates from the hypothetical normal 45°-angled
correlation curve for the case of ideal fit.
These findings are clarified furthermore by displaying the extent
and the direction of the differences of tumor volume calculations by
the two methods, individually for each tumor displayed in Table 1
(Figure 2E). Figure 2E shows, that independent of the direction of the
estimation (positive range meaning overestimation, negative range
meaning underestimation), in five out of seven cases the ultrasound
method proves superior over the caliper/formula method. This is true
for both kinds of density estimations on the reference method, when
looking at the left half or right half of the figure separately. Especially
in the case of large tumor volume differences, e.g. for tumor 6, the
ultrasound method produces better estimates.
Discussion
One of the most important predictors for clinical and preclinical
treatment outcome and an experimentally, on first glance, “easy-to-
follow” aspect in tumor biology is the speed of tumor growth and the
associated tumor volume increase. In many solid tumors, this increase
in volume is not only attributed to an increase in tissue “material” on
a cellular level, but also to an elevated tumor interstitial fluid pressure
(TIFP) [1,14–17]. The TIFP is also partly responsible for creating the
tension upholding the individual tumor shape, which in “ideal” case is
a spherical/ellipsoid form.
Tumor volume studies have had a big impact on clinical as well as
preclinical studies, because influences of tumor treatment are directly
associated with tumor volume changes and can be easily followed in
animal experiments. Volume measurement methods used by
practitioners working with tumor-bearing mice though often lack
the desired precision, as they are conducted by using steel or
electronic calipers. The tumor volume is then calculated with the
standard ellipsoid formula π/6 w(idth) d(epth) l(ength). Moreover,
this method lacks reproducibility which is tried to overcome by
repeated measurements and use of mean values for these measure-
ments. One additional disadvantage of the hands-on procedure is not
only its dependency on the user skills (the same holds true for the use
of UBM on-screen-calipers, as shown by Cheung et al. [4], but as welltion (VW) and density estimation with literature value (VL) (Gold standards VW and VL) b) ellipsoid formula/
Volume [mm3] VL Volume [mm









Figure 2. Comparison of volume calculation via gold standard with ARTIDA and caliper method. A) Artida (VA) and Caliper (VE)
measurements are compared to the gold standard volume determination method (VL). B) Artida (VA) and Caliper (VE) measurements are
compared to the second gold standard volume determination method (VW). C) Bland-Altman plot of tumor volume difference calculations
by two different methods. D) Correlation plot of tumor volume difference calculations by two different methods. E) Deviations of tumor
volume measurements for individual tumors. Green bars indicate Artida measurement proves superior over the caliper/formula method.
Red bars indicate caliper/formula measurement is superior over the Artida method. *P = .05.
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longer available, as there is no “raw” dataset to store.
In the presented work we tried to evaluate the usefulness and
accuracy of modern, 3D ultrasound imaging including a speckle
tracking algorithm software to track tumor outline borders and
segmentationally reconstruct 3D tumor volumes. To account for a
wide variability of samples, A431 tumors with varying growth time
and resulting differences in end volume were chosen. The 3D-
ultrasound method was finally compared to the conventional caliper
method pertaining to the amount of possible deviations in our ex-vivo
measurements, using two different types of reference volume
estimations as gold standards.
The data we present in this study with subcutaneously grown
tumor xenografts shows only a mediocre correlation between thecaliper-and-formula calculated tumor volumes and the data generated
by ultrasound, as demonstrated by a statistical correlation value of
only r = 0.5. However, when comparing both methods directly, the
plots also reveal a strong overestimation of tumor volumes by the
conventional method, prominently seen in tumors with higher end
volume. A possible reason for these findings is that when measuring
with calipers, either tumor hull, and/or especially with in-situ
measurements on (nude) mice, the thickness of the dermal and
subdermal skin tissue layers have to be taken into account. As these
layers are slightly movable against each other and also add up in the
three orthogonal planes of measurement, it becomes evident that they
account for a major overestimation error of real tumor volume. For
early developing xenografts, these findings are corroborated by the
experimental studies of Cheung et al. [4]. For more irregular tumor
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experiments, we expect this problem to be even more pronounced.
Tumor volume estimation via 3D-ultrasound seems to generate far
more accurate results than the conventional method which is prone to
intra-observer variability. The differences to the widespread conven-
tional caliper method are pronounced even for the majority of tumors
which do not exceed the end volume of 900 mm3 and more. In cases
of higher tumor end volume, the ultrasound method seems to work
even better, as the cases of tumor 6 and 7 show in exemplary fashion
(Figure 2E). Of course, studies of these kinds find their limitations in
the high heterogeneity in tumor end volumes even when generated
from the same initial amount of cells and from the same tumor entity
in a controlled set of mice.
There were various attempts to non-invasively quantify tumor
volume of subcutaneously grown tumors in small animals before, one
of them being the use of mesoscopic epi-fluorescence tomography and
epi-illumination reflectance imaging, as recently shown by Abou-
Elkacem et al. [18]. However, these methods make use of specific
fluorescence labeling and require injection of green/red fluorescent
substances into the tumor tissue.
In conclusion we identified that three-dimensional sonographic
imaging, as carried out in this study in conjunction with a speckle
tracking algorithm, is a suited technology to non-invasively assess tumor
volume in subcutaneous tumors. Moreover, it was shown that this
technology produces more reliable tumor volume estimates in a certain
variety of tumor types and volume ranges than conventional techniques.
The technology is relatively easy to handle (hazard-free) and requires
only standard medical-type of ultrasound transducers, which might
open access of 3D-ultrasound from daily patient-oriented medical
scenarios to encompass a wider preclinical and research use.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.tranon.2014.09.013.
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